Key Highlights
- Elise Berman, M.D., joins Delphinus Medical Technologies as Medical Director.
- Dr. Berman brings 22 years of expertise from Fairfax Radiological Consultants.
- SoftVue™ technology addresses breast cancer screening in women with dense breasts.
Source: Business Wire
Notable Quotes
- “I’ve spent most of my career understanding and developing breast imaging programs, including centers of excellence, and have become well-versed in how an imaging department functions and operates at maximum capability and efficiency.” — Elise Berman, Medical Director at Delphinus Medical Technologies
- “There is no group more familiar with the struggles of women with dense breasts than those who care for them, and Dr. Berman has had intimate experience with this patient population throughout her career.” — Scott White, CEO at Delphinus Medical Technologies
SoHC's Take
The addition of Dr. Elise Berman to Delphinus Medical Technologies as Medical Director is a significant milestone for the company. Her extensive background in breast imaging and leadership at Fairfax Radiological Consultants positions her well to drive the adoption and implementation of SoftVue™, a revolutionary breast tomographic ultrasound system. This technology not only enhances cancer detection rates in women with dense breasts but also reduces the stress and cost associated with false positives and unnecessary procedures. Dr. Berman’s expertise will be invaluable in guiding Delphinus towards improving patient outcomes and expanding their impact in the breast imaging sector.
